Wälchli S - Search Results

1

Transient TCR-based T cell therapy in a patient with advanced treatment-resistant MSI-high colorectal cancer.

Maggadottir SM, Dueland S, Mensali N, Hamre H, Andresen PA, Myhre MR, Juul HV, Bigalke I, Lundby M, Hønnåshagen TK, Sæbøe-Larssen S, Josefsen D, Hagtvedt T, Wälchli S, Kvalheim G, Inderberg EM. Maggadottir SM, et al. Among authors: walchli s. Mol Ther. 2024 Apr 6:S1525-0016(24)00225-9. doi: 10.1016/j.ymthe.2024.04.009. Online ahead of print. Mol Ther. 2024. PMID: 38582964 Free article.

2

Identification of tyrosine phosphatases that dephosphorylate the insulin receptor. A brute force approach based on "substrate-trapping" mutants.

Wälchli S, Curchod ML, Gobert RP, Arkinstall S, Hooft van Huijsduijnen R. Wälchli S, et al. J Biol Chem. 2000 Mar 31;275(13):9792-6. doi: 10.1074/jbc.275.13.9792. J Biol Chem. 2000. PMID: 10734133 Free article.

3

Golgi vesiculation induced by cholesterol occurs by a dynamin- and cPLA2-dependent mechanism.

Grimmer S, Ying M, Wälchli S, van Deurs B, Sandvig K. Grimmer S, et al. Among authors: walchli s. Traffic. 2005 Feb;6(2):144-56. doi: 10.1111/j.1600-0854.2005.00258.x. Traffic. 2005. PMID: 15634214 Free article.

4

SNX4 in complex with clathrin and dynein: implications for endosome movement.

Skånland SS, Wälchli S, Brech A, Sandvig K. Skånland SS, et al. Among authors: walchli s. PLoS One. 2009 Jun 16;4(6):e5935. doi: 10.1371/journal.pone.0005935. PLoS One. 2009. PMID: 19529763 Free PMC article.

5

Protein tyrosine phosphatases as drug targets: PTP1B and beyond.

Hooft van Huijsduijnen R, Wälchli S, Ibberson M, Harrenga A. Hooft van Huijsduijnen R, et al. Among authors: walchli s. Expert Opin Ther Targets. 2002 Dec;6(6):637-47. doi: 10.1517/14728222.6.6.637. Expert Opin Ther Targets. 2002. PMID: 12472377 Review.

6

Enigma homolog 1 scaffolds protein kinase D1 to regulate the activity of the cardiac L-type voltage-gated calcium channel.

Maturana AD, Wälchli S, Iwata M, Ryser S, Van Lint J, Hoshijima M, Schlegel W, Ikeda Y, Tanizawa K, Kuroda S. Maturana AD, et al. Among authors: walchli s. Cardiovasc Res. 2008 Jun 1;78(3):458-65. doi: 10.1093/cvr/cvn052. Epub 2008 Feb 23. Cardiovasc Res. 2008. PMID: 18296710 Free PMC article.

7

A single point mutation in ricin A-chain increases toxin degradation and inhibits EDEM1-dependent ER retrotranslocation.

Sokołowska I, Wälchli S, Węgrzyn G, Sandvig K, Słomińska-Wojewódzka M. Sokołowska I, et al. Among authors: walchli s. Biochem J. 2011 Jun 1;436(2):371-85. doi: 10.1042/BJ20101493. Biochem J. 2011. PMID: 21388347

8

Transiently redirected T cells for adoptive transfer.

Almåsbak H, Rian E, Hoel HJ, Pulè M, Wälchli S, Kvalheim G, Gaudernack G, Rasmussen AM. Almåsbak H, et al. Among authors: walchli s. Cytotherapy. 2011 May;13(5):629-40. doi: 10.3109/14653249.2010.542461. Epub 2010 Dec 21. Cytotherapy. 2011. PMID: 21174490

9

T cells raised against allogeneic HLA-A2/CD20 kill primary follicular lymphoma and acute lymphoblastic leukemia cells.

Abrahamsen IW, Kjellevoll S, Greve-Isdahl M, Mensali N, Wälchli S, Kumari S, Loland BF, Egeland T, Kolstad A, Olweus J. Abrahamsen IW, et al. Among authors: walchli s. Int J Cancer. 2012 Apr 15;130(8):1821-32. doi: 10.1002/ijc.26209. Epub 2011 Aug 12. Int J Cancer. 2012. PMID: 21630262 Free article.

10

Unpredicted phenotypes of two mutants of the TcR DMF5.

Tadesse FG, Mensali N, Fallang LE, Walseng E, Yang W, Olweus J, Wälchli S. Tadesse FG, et al. Among authors: walchli s. J Immunol Methods. 2015 Oct;425:37-44. doi: 10.1016/j.jim.2015.06.006. Epub 2015 Jun 14. J Immunol Methods. 2015. PMID: 26079729

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

92 results

Search Page